Literature DB >> 26471267

Deubiquitinases Modulate Platelet Proteome Ubiquitination, Aggregation, and Thrombosis.

Nilaksh Gupta1, Wei Li1, Thomas M McIntyre2.   

Abstract

OBJECTIVE: Platelets express a functional ubiquitin-proteasome system. Mass spectrometry shows that platelets contain several deubiquitinases, but whether these are functional, modulate the proteome, or affect platelet reactivity are unknown. APPROACH AND
RESULTS: Platelet lysates contained ubiquitin-protein deubiquitinase activity hydrolyzing both Lys48 and Lys63 polyubiquitin conjugates that was suppressed by the chemically unrelated deubiquitinase inhibitors PYR41 and PR619. These inhibitors acutely and markedly increased monoubiquitination and polyubiquitination of the proteome of resting platelets. PYR41 (intravenous, 15 minutes) significantly impaired occlusive thrombosis in FeCl3-damaged carotid arteries, and deubiquitinase inhibition reduced platelet adhesion and retention during high shear flow of whole blood through microfluidic chambers coated with collagen. Total internal reflection microscopy showed that adhesion and spreading in the absence of flow were strongly curtailed by these inhibitors with failure of stable process extension and reduced the retraction of formed clots. Deubiquitinase inhibition also sharply reduced homotypic platelet aggregation in response to not only the incomplete agonists ADP and collagen acting through glycoprotein VI but also to the complete agonist thrombin. Suppressed aggregation was accompanied by curtailed procaspase activating compound-1 binding to activated IIb/IIIa and inhibition of P-selectin translocation to the platelet surface. Deubiquitinase inhibition abolished the agonist-induced spike in intracellular calcium, suppressed Akt phosphorylation, and reduced agonist-stimulated phosphatase and tensin homolog phosphatase phosphorylation. Platelets express the proteasome-associated deubiquitinases USP14 and UCHL5, and selective inhibition of these enzymes by b-AP15 reproduced the inhibitory effect of the general deubiquitinase inhibitors on ex vivo platelet function.
CONCLUSIONS: Remodeling of the ubiquitinated platelet proteome by deubiquitinases promotes agonist-stimulated intracellular signal transduction and platelet responsiveness.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  blood platelets; proteasome endopeptidase complex; thrombosis; ubiquitin; ubiquitin-specific protease

Mesh:

Substances:

Year:  2015        PMID: 26471267      PMCID: PMC4662625          DOI: 10.1161/ATVBAHA.115.306054

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  43 in total

1.  Inhibition of protein deubiquitination by PR-619 activates the autophagic pathway in OLN-t40 oligodendroglial cells.

Authors:  Veronika Seiberlich; Janika Borchert; Victoria Zhukareva; Christiane Richter-Landsberg
Journal:  Cell Biochem Biophys       Date:  2013-09       Impact factor: 2.194

Review 2.  Proteasome deubiquitinases as novel targets for cancer therapy.

Authors:  Pádraig D'Arcy; Stig Linder
Journal:  Int J Biochem Cell Biol       Date:  2012-07-20       Impact factor: 5.085

3.  Inhibition of proteasome deubiquitinating activity as a new cancer therapy.

Authors:  Pádraig D'Arcy; Slavica Brnjic; Maria Hägg Olofsson; Mårten Fryknäs; Kristina Lindsten; Michelandrea De Cesare; Paola Perego; Behnam Sadeghi; Moustapha Hassan; Rolf Larsson; Stig Linder
Journal:  Nat Med       Date:  2011-11-06       Impact factor: 53.440

4.  A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance.

Authors:  Ze Tian; Padraig D'Arcy; Xin Wang; Arghya Ray; Yu-Tzu Tai; Yiguo Hu; Ruben D Carrasco; Paul Richardson; Stig Linder; Dharminder Chauhan; Kenneth C Anderson
Journal:  Blood       Date:  2013-12-06       Impact factor: 22.113

5.  Lysine 63-linked ubiquitination is important for arachidonic acid-induced cellular adhesion and migration.

Authors:  Denise M Ray; Brian A Rogers; Jeffrey A Sunman; Steven K Akiyama; Kenneth Olden; John D Roberts
Journal:  Biochem Cell Biol       Date:  2010-12       Impact factor: 3.626

Review 6.  PI 3-Kinase p110β regulation of platelet integrin α(IIb)β3.

Authors:  Shaun P Jackson; Simone M Schoenwaelder
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 7.  Protein degradation systems in platelets.

Authors:  B F Kraemer; A S Weyrich; S Lindemann
Journal:  Thromb Haemost       Date:  2013-09-19       Impact factor: 5.249

8.  Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes.

Authors:  Mikael Altun; Holger B Kramer; Lianne I Willems; Jeffrey L McDermott; Craig A Leach; Seth J Goldenberg; K G Suresh Kumar; Rebecca Konietzny; Roman Fischer; Edward Kogan; Mukram M Mackeen; Joanna McGouran; Svetlana V Khoronenkova; Jason L Parsons; Grigory L Dianov; Benjamin Nicholson; Benedikt M Kessler
Journal:  Chem Biol       Date:  2011-11-23

9.  mTORC2 protein complex-mediated Akt (Protein Kinase B) Serine 473 Phosphorylation is not required for Akt1 activity in human platelets [corrected].

Authors:  Samantha F Moore; Roger W Hunter; Ingeborg Hers
Journal:  J Biol Chem       Date:  2011-05-18       Impact factor: 5.157

10.  Ferric chloride-induced murine carotid arterial injury: A model of redox pathology.

Authors:  Wei Li; Thomas M McIntyre; Roy L Silverstein
Journal:  Redox Biol       Date:  2013-01-26       Impact factor: 11.799

View more
  12 in total

1.  SHARPIN at the nexus of integrin, immune, and inflammatory signaling in human platelets.

Authors:  Ana Kasirer-Friede; Winson Tjahjono; Koji Eto; Sanford J Shattil
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-25       Impact factor: 11.205

2.  Epidermal Growth Factor (EGF) Autocrine Activation of Human Platelets Promotes EGF Receptor-Dependent Oral Squamous Cell Carcinoma Invasion, Migration, and Epithelial Mesenchymal Transition.

Authors:  Rui Chen; Ge Jin; Wei Li; Thomas M McIntyre
Journal:  J Immunol       Date:  2018-08-27       Impact factor: 5.422

3.  Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition.

Authors:  Florian Beck; Jörg Geiger; Stepan Gambaryan; Fiorella A Solari; Margherita Dell'Aica; Stefan Loroch; Nadine J Mattheij; Igor Mindukshev; Oliver Pötz; Kerstin Jurk; Julia M Burkhart; Christian Fufezan; Johan W M Heemskerk; Ulrich Walter; René P Zahedi; Albert Sickmann
Journal:  Blood       Date:  2016-11-09       Impact factor: 22.113

4.  Hypoxia and Ischemia Promote a Maladaptive Platelet Phenotype.

Authors:  Scott J Cameron; Doran S Mix; Sara K Ture; Rachel A Schmidt; Amy Mohan; Daphne Pariser; Michael C Stoner; Punit Shah; Lijun Chen; Hui Zhang; David J Field; Kristina L Modjeski; Sandra Toth; Craig N Morrell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-05-03       Impact factor: 8.311

5.  Ferric Chloride-induced Murine Thrombosis Models.

Authors:  Wei Li; Marvin Nieman; Anirban Sen Gupta
Journal:  J Vis Exp       Date:  2016-09-05       Impact factor: 1.355

6.  A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors.

Authors:  Ina Nemet; Prasenjit Prasad Saha; Nilaksh Gupta; Weifei Zhu; Kymberleigh A Romano; Sarah M Skye; Tomas Cajka; Maradumane L Mohan; Lin Li; Yuping Wu; Masanori Funabashi; Amanda E Ramer-Tait; Sathyamangla Venkata Naga Prasad; Oliver Fiehn; Federico E Rey; W H Wilson Tang; Michael A Fischbach; Joseph A DiDonato; Stanley L Hazen
Journal:  Cell       Date:  2020-03-05       Impact factor: 41.582

7.  UBE2T knockdown inhibits gastric cancer progression.

Authors:  Changjiang Luo; Yunyi Yao; Zeyuan Yu; Huinian Zhou; Lingyun Guo; Junqiang Zhang; Hongtai Cao; Genyuan Zhang; Yumin Li; Zuoyi Jiao
Journal:  Oncotarget       Date:  2017-05-16

Review 8.  Platelets in Healthy and Disease States: From Biomarkers Discovery to Drug Targets Identification by Proteomics.

Authors:  Erica Gianazza; Maura Brioschi; Roberta Baetta; Alice Mallia; Cristina Banfi; Elena Tremoli
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

9.  micro-RNAs dependent regulation of DNMT and HIF1α gene expression in thrombotic disorders.

Authors:  Aatira Vijay; Prabhash Kumar Jha; Iti Garg; Manish Sharma; Mohammad Zahid Ashraf; Bhuvnesh Kumar
Journal:  Sci Rep       Date:  2019-03-20       Impact factor: 4.379

10.  Human Platelet Protein Ubiquitylation and Changes following GPVI Activation.

Authors:  Amanda J Unsworth; Izabela Bombik; Adan Pinto-Fernandez; Joanna F McGouran; Rebecca Konietzny; René P Zahedi; Steve P Watson; Benedikt M Kessler; Catherine J Pears
Journal:  Thromb Haemost       Date:  2018-12-31       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.